Ownership signal CIK-linked ownership evidence from parsed SEC filings. 2 signals
Large-stake signal

Form

SCHEDULE 13G/A

Passive or exempt beneficial ownership filing.

Ownership

8.9%

Beneficial ownership of this reported class.

Shares

5,733,021 shares

Shares beneficially owned as disclosed.

Event date

31 Mar 2026

Date tied to the ownership event or amendment.

Accepted by SEC

15 May 2026

EDGAR acceptance date.

How to read this large-stake filing
  • Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
  • Compare this filing with the holder history and issuer page before treating the percentage as a current position.
  • Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
Subject security Names, identifiers, and filing context for this profile. 2 source fields
Symbol
EQ
Shares outstanding
64,415,966 shares
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
SCHEDULE 13G/A
Accepted by SEC
15 May 2026, 16:13:29 UTC
Event date
31 Mar 2026
Source filing
View source filing

Key filing fact

Decheng Capital Management IV (Cayman), LLC disclosed 8.9% ownership in EQUILLIUM, INC. Common Stock, par value $0.001 per share (EQ) on 31 Mar 2026.

Key facts

  • Decheng Capital Management IV (Cayman), LLC filed SCHEDULE 13G/A for EQUILLIUM, INC. Common Stock, par value $0.001 per share (EQ).
  • Disclosed ownership: 8.9%.
  • Date of event: 31 Mar 2026.

Change

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 15 May 2026, 16:13.

Research use

  • This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
  • Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

View source filing

Reporting persons

Disclosed reporting parties (5)

Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares owned Sole voting power Shared voting power Signature Title CIK
Decheng Capital Management IV (Cayman), LLC 6.7% 4,271,423 0 4,271,423 /s/ Xiangmin Cui By Xiangmin Cui, Manager
Decheng Capital Global Life Sciences Fund IV, L.P. 6.7% 4,271,423 0 4,271,423 /s/ Xiangmin Cui By Decheng Capital Management IV (Cayman), LLC, its General Partner, By Xiangmin Cui, Manager
Decheng Capital Global Healthcare Fund (Master), LP 2.3% 1,461,598 0 1,461,598 /s/ Xiangmin Cui By Decheng Capital Global Healthcare GP, LLC, its General Partner, By Decheng Capital LLC, its Manager, By Xiangmin Cui, Manager
Decheng Capital Global Healthcare GP, LLC 2.3% 1,461,598 0 1,461,598 /s/ Xiangmin Cui By Decheng Capital LLC, its Manager, By Xiangmin Cui, Manager
Xiangmin Cui 8.9% 5,733,021 0 5,733,021 /s/ Xiangmin Cui Xiangmin Cui
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .